Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Bioengineering a Human Airway Mimetic for Preclinical Use in Disease Modelling Cystic Fibrosis

FY 2021-22

Summary
Cystic fibrosis (CF) is a genetic disease that affects over 4000 children and young adults in Canada. While it is a multi-organ disease resulting in an imbalance of water and salt, it severely impacts lung function. Specifically, CF individuals deal with thick, dehydrated mucus secretions in their airways, resulting in difficulty breathing and clearing their airway of debris and pathogens. This can lead to repeated lung infections and chronic inflammation. There is no universal cure for CF because not everyone shares the same mutation, and available drugs are costly, and their efficacy varies based on an individual's mutation. This highlights the need for personalized medicine to treat CF; however, physiologically relevant study models for humans are lacking. Animal models are not truly representative of human conditions, and human cells grown on plates are an oversimplification of the airway environment. This project aims to create the first artificial airway for near-term use in disease modelling and personalized therapy discovery. In collaboration with the University of Toronto's Mechanical Engineering department, we will be accounting for the airway's physical structure. Our goal is to create a functionally accurate mimetic that can reflect realistic human responses to CF outside the body. We will use novel bioprinting technology to print tubes and seed patient-derived stem cells to mimic the airway structure while exposed to airflow. Using patient-derived stem cells suggests specific drugs can be selected and tested for on the model to determine their efficacy in treating a particular patient. Therefore, creating a physiologically relevant model is vital to observing and understanding realistic responses to CF and developing effective treatment options.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466698
Name
Kanagarajah Kayshani R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Bioengineering a Human Airway Mimetic for Preclinical Use in Disease Modelling Cystic Fibrosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
3d Model; Airway; Bioengineering; Cystic Fibrosis; Disease Modelling; Drug Testing; Induced Pluripotent Stem Cells; Lung Airway Model; Microfluidics; Precision Medicine
Abstract
Cystic fibrosis (CF) is a genetic disease that affects over 4000 children and young adults in Canada. While it is a multi-organ disease resulting in an imbalance of water and salt, it severely impacts lung function. Specifically, CF individuals deal with thick, dehydrated mucus secretions in their airways, resulting in difficulty breathing and clearing their airway of debris and pathogens. This can lead to repeated lung infections and chronic inflammation. There is no universal cure for CF because not everyone shares the same mutation, and available drugs are costly, and their efficacy varies based on an individual's mutation. This highlights the need for personalized medicine to treat CF; however, physiologically relevant study models for humans are lacking. Animal models are not truly representative of human conditions, and human cells grown on plates are an oversimplification of the airway environment. This project aims to create the first artificial airway for near-term use in disease modelling and personalized therapy discovery. In collaboration with the University of Toronto's Mechanical Engineering department, we will be accounting for the airway's physical structure. Our goal is to create a functionally accurate mimetic that can reflect realistic human responses to CF outside the body. We will use novel bioprinting technology to print tubes and seed patient-derived stem cells to mimic the airway structure while exposed to airflow. Using patient-derived stem cells suggests specific drugs can be selected and tested for on the model to determine their efficacy in treating a particular patient. Therefore, creating a physiologically relevant model is vital to observing and understanding realistic responses to CF and developing effective treatment options.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kanagarajah, Kayshani R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~